Lynn Tyler helps innovative companies secure and preserve their market position and competitive advantage. He advises on FDA compliance, helps protect clients with patent infringement and validity opinions, helps and enforce intellectual property rights — which often must be asserted against imitators who seek to reap where they have not sown.
An accomplished advocate, Lynn litigates and represents clients involved in virtually all stages of the dispute resolution process, including pre-litigation counseling, alternative dispute resolution, formal and informal discovery, trial and appeal. As chair of the firm’s Food, Drug and Device practice group, Lynn counsels food industry clients on matters such as advertising and promotion, FDA inspections, imports, labeling, registration, reporting and packaging. He also advises medical device companies on matters such as inspections, 510(k)s, and labeling and promotion issues.
Lynn has represented clients in federal courts throughout the country in cases involving patents, trademarks and trade dress, trade secrets, antitrust, noncompete agreements and unfair competition. Some of the technologies in which Lynn has been involved include agricultural chemicals, artificial hips, automotive carbon canisters, fuel caps and thermostats, ballistics software, blood glucose monitors and other blood assays and analyzers, cable television test equipment, cement kilns, e-commerce software, pharmaceuticals and spinal implants.
Notably, Lynn has participated in more than 20 trials and evidentiary hearings in patent cases and other complex commercial matters. For appellate matters, he has served as lead counsel in over 30 cases before the U.S. Supreme Court and various federal and state courts.
He is the author of numerous articles and two book chapters on issues of intellectual property, FDA law and federal procedure published in a variety of peer-reviewed publications.
More Legal and Business Bylines From Lynn C. Tyler, M.S.
- Food and Drug Administration (FDA) Extends Comment Periods for Food-Related Rules and Guidance - (Posted On Tuesday, November 26, 2013)
- Food and Drug Administration (FDA) Officials Speak at Indiana Device Manufacturers Meeting - (Posted On Wednesday, November 13, 2013)
- Food and Drug Administration (FDA) Begins Process to Ban Adding Trans Fats to Food - (Posted On Monday, November 11, 2013)
- Food and Drug Administration (FDA) Finalizes Guidance on Mobile Medical Apps - (Posted On Saturday, October 05, 2013)
- Food and Drug Administration (FDA) Finalizes Rule on Unique Device Identification - (Posted On Tuesday, September 24, 2013)
- FDA Issues Draft Guidance on Definition of Denying, Delaying, Limiting or Refusing to Permit Inspection - (Posted On Wednesday, August 07, 2013)
- Federal District Courts Request FDA to Define “Natural” With Respect to Genetically-Modified Organisms (GMO) Foods - (Posted On Friday, August 02, 2013)
- Food and Drug Administration (FDA) Issues Proposed Rule on Accreditation of Third-Party Auditors for Food Safety - (Posted On Thursday, August 01, 2013)
- Food and Drug Administration (FDA) Issues Proposed Rule on Foreign Supplier Verification Program for Food Safety - (Posted On Wednesday, July 31, 2013)
- FDA Issues Draft Guidance on Medical Device Reporting for Manufacturers - (Posted On Friday, July 12, 2013)
Lynn C. Tyler, an intellectual property & compliance lawyer and 2019 National Law Review Go-To Thought Leader, advises innovative companies on US Food and Drug Adminstration (FDA) compliance, patent infringement, and validity options. As chair of Barnes & Thornburg’s Food, Drug and Device practice group, Mr. Tyler provides NLR readers with a experienced look at the evolving state of medical device regulation.